|
AU2015202499A1
|
|
Solubility optimization of immunobinders
|
|
AU2014215955A1
|
|
Functionalized polypeptides
|
|
WO2011075861A1
|
|
Method for decreasing immunogenicity
|
|
EP2303230A2
|
|
Methods and compositions for enhanced delivery of macromolecules
|
|
CA2727839A1
|
|
Stable and soluble antibodies inhibiting vegf
|
|
CN105418763A
|
|
Solubility Optimization Of Immunobinders
|
|
MX2011000052A
|
|
Humanization of rabbit antibodies using a universal antibody framework.
|
|
HUE027507T2
|
|
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
NZ581470A
|
|
Sequence based engineering and optimization of single chain antibodies
|
|
NZ710254A
|
|
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
NZ625731A
|
|
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
|
CN101668771A
|
|
Sequence based engineering and optimization of single chain antibodies
|
